Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Endovion shows promising results in preclinical and phase I studies

July 4, 2003

Trials confirm the efficacy and safety of bortezomib in multiple myeloma and mantle cell lymphoma

July 4, 2003

Genmab files CTA to begin phase I/II trial of HuMax-EGFr

July 4, 2003

Genasense receives fast track designation in CLL

July 4, 2003

Fast track designation awarded to Avastin

July 4, 2003

Final phase II/III data confirms interim Onco TCS results

July 4, 2003

New commercialization and development agreement for Velcade

July 4, 2003

Pivanex studied in combination with docetaxel for NSCLC

July 3, 2003

New phase I/II trial of Dacogen plus carboplatin for advanced solid tumors

July 3, 2003

Positive opinion for Onsenal in familial adenomatous polyposis in Europe

July 3, 2003

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...